Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease

摘要

The invention provides compounds of Formula (I), wherein Azabicyclo is formulas (II-VII), W is formulas (VIII-X). These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which alpha 7 is known to be involved.